Bioactivity:

Ervogastat is a potent and well-tolerated diacylglycerol acyltransferase 2 inhibitor. Ervogastat reduces steatosis and hepatic triglyceride levels in non-alcoholic steatohepatitis (NASH).

CAS nr:

2186700-33-2

Purity:

98%

Molecular Weight:

407,42

SMILES:

O=C(C1=CN=C(C2=CC(OC3=NC=CC=C3OCC)=CN=C2)N=C1)N[C@@H]4COCC4

Formula:

C21H21N5O4

Pathway:

Metabolism

Target:

Transferase